All About Us

Who We Are

We are a world renowned team of experts that come from all over the world to work in state-of-the-art labs.

View Staff Directory

In Our Labs

Discoveries Are Made Everyday

Since opening its doors in 2003, The Roskamp Institute, a 501(c)(3) nonprofit organization, has been a leader in the global effort to better understand and treat diseases of the mind. The foundation for the Institute’s work was set more than a decade ago by the Institute’s two lead researchers, Drs. Michael Mullan and Fiona Crawford.

They were key members of a pioneering team of scientists who, in the early 1990s, , discovered the first known mutations causing early onset Alzheimer’s Disease in the amyloid gene.

Executive Leadership

Fiona Crawford, Ph.D

President & CEO

Dr. Crawford is a molecular geneticist and neuroscientist, and co-founder of The Roskamp Institute. She has more than 30 years of experience, and 186 publications, in the field of research and development for Alzheimer’s disease, Traumatic Brain Injury and related disorders.

Michael Mullan, M.D., Ph.D

Executive Director

Dr. Mullan trained both as a physician, treating patients with neuropsychiatric diseases, and also as a neuroscientist. He has authored over 300 scientific publications on Alzheimer’s Disease and other neurological disorders and focuses on finding new treatments for them. Along with Bob and Diane Roskamp and Dr. Fiona Crawford he co-founded The Roskamp Institute.

Stefan Crynen, Ph.D

Chief Operating Officer

Dr. Crynen holds an engineering degree from the University of Applied Science in Trier (Germany), followed by a Master of Science and PhD degree in Food Science from the University of Florida. Dr. Crynen has more than 10 years of multidisciplinary experience in the fields of Food Science, Nutraceuticals and Pharmaceuticals.